MSTS and the Research Committee, led by Chair Dr. Bang Hoang, are pleased to congratulate the following recipients:
The 2025 Benign Musculoskeletal Tumor Research Award ($25,000) was received by:
- Dr. Christopher D. Hamad of UCLA for his research titled: Biomarkers of Non-Response to CSF1R Inhibitors in Tenosynovial Giant Cell Tumor
The 2025 Bone Metastasis Research Award ($25,000) was received by:
- Dr. Meredith Bartelstein of Memorial Sloan Kettering Institute for Cancer Research for her research titled: Activity Monitors to Measure Perioperative Function in Bone Metastasis
The 2025 Sarcoma Strong Mentored Research Award ($25,000) was received by:
- Dr. Shalin Patel of MD Anderson Cancer Center for his research titled: Financial Toxicity in Patients with Localized Primary Bone and Soft Tissue Sarcomas
The 2025 Sarcoma Strong Research Grant Award ($50,000) was received by:
- Dr. Sean Kelly of Tripler Army Medical Center for his research titled: In Vitro Comparison of RANKL and Sclerostin Inhibition in Patient Derived Cell-line Models of Giant Cell Tumor of Bone
In 2024, the Sarcoma Strong Career Catalyst Award ($100,000 over a two-year period) was received by:
- Dr. Julia Visgauss, of Duke University for her research titled: Investigating drivers and therapeutic approaches for LCP1 overexpression in chondrosarcoma
The 2024 Sarcoma Strong Mentored Research Award ($25,000) was received by:
- Dr. Zachary Burke of Cleveland Clinic for his research titled: Clonal Profiling of MAP resistant osteosarcoma to inform evolutionarily guided treatment strategies
Congratulations to both of these distinguished MSTS members on their outstanding research projects!
Are you interested in applying?
Please click here for additional information, to view the Research Funding Announcements, and to apply.